The Impact of DNA Repair Pathway Alterations Identified by Circulating Tumor DNA on Sensitivity to Radium-223 in Bone Metastatic Castration-Resistant Prostate Cancer
Latest Information Update: 21 Aug 2024
Price :
$35 *
At a glance
- Drugs Radium 223 chloride (Primary)
- Indications Bone metastases; Prostate cancer
- Focus Therapeutic Use
- 19 Aug 2024 Planned number of patients changed from 60 to 48.
- 19 Aug 2024 Planned primary completion date changed from 1 Aug 2024 to 1 Aug 2025.
- 27 May 2022 Planned End Date changed from 1 Aug 2027 to 1 Aug 2028.